Aurenar’s V-Link system uses transauricular vagus nerve stimulation to modulate brain inflammation in patients that have experienced a stroke.

Novocure has received CE Mark for Optune Pax, its portable medical device intended to treat adults with locally advanced pancreatic cancer of exocrine origin.

Artivion has received the PMA clearance from the US FDA for AMDS Hybrid Prosthesis device, permitting its use in treating acute DeBakey Type I aortic dissections with clinical or radiographic ...

The initiative is designed to simplify the ability for GE HealthCare customers with existing interventional suites to access new technologies.

Experts at HLTH Europe 2026 agreed that healthcare innovations won't meet their full potential until healthcare services can implement them.

The deal is Merck’s largest since 2015, when it spent $17bn on acquiring Sigma-Aldrich, also a life sciences specialist.

Roche has introduced its Axelios 1 platform, a next-generation sequencing system that is available for research use and powered by its SBX technology.

Experts at HLTH Europe 2026 note that patient adherence-focused health technologies should be flexible, engaging, adaptable and affordable.

HB Fuller says the AMS acquisition would expand its TAM by $15bn, while bringing in around $300m in extra annual revenue.

Tissium will now bring COAPTIUM CONNECT, the first atraumatic peripheral nerve repair surgical system, to patients in the US.

Quest Diagnostics has received approval from the NYSDOH CLEP for its Haystack MRD test, expanding its use to cancer patients throughout the US.

According to the World Stroke Organisation (WSO), among non-communicable disorders (NCDs), stroke remains the second leading cause of death and the third leading cause of death and disability combined ...